BIOMAT Database Logo BIOMAT Database Logo

Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis. 1993

J Boukadida, and M De Montalembert, and G Lenoir, and P Scheinmann, and M Véron, and P Berche
Laboratoire de Microbiologie, Hôpital Necker-Enfants Malades, Paris, France.

The epidemiology of pulmonary colonisation by Pseudomonas aeruginosa was studied in 21 patients with cystic fibrosis (CF) by field inversion gel electrophoresis. DraI-DNA restriction patterns were analysed for 187 P. aeruginosa isolates from these patients. The results revealed that the strains present in individual patients varied during the course of chronic colonisation; the emergence of new strains often was associated with periods of antibiotic therapy. Patients often were colonised by more than one strain (two or three strains were present in 54% of the patients) and the strains obtained from unrelated patients were highly heterogeneous, in contrast to those isolated from a pair of twins. These results demonstrate the heterogeneity and variability of P. aeruginosa isolates in the pulmonary flora of chronically infected CF patients.

UI MeSH Term Description Entries
D008297 Male Males
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D004587 Electrophoresis, Agar Gel Electrophoresis in which agar or agarose gel is used as the diffusion medium. Electrophoresis, Agarose Gel,Agar Gel Electrophoresis,Agarose Gel Electrophoresis,Gel Electrophoresis, Agar,Gel Electrophoresis, Agarose

Related Publications

J Boukadida, and M De Montalembert, and G Lenoir, and P Scheinmann, and M Véron, and P Berche
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.
September 1991, Lancet (London, England),
J Boukadida, and M De Montalembert, and G Lenoir, and P Scheinmann, and M Véron, and P Berche
Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis.
January 2012, PloS one,
J Boukadida, and M De Montalembert, and G Lenoir, and P Scheinmann, and M Véron, and P Berche
Treatment of pseudomonas aeruginosa colonisation in cystic fibrosis.
July 1989, Archives of disease in childhood,
J Boukadida, and M De Montalembert, and G Lenoir, and P Scheinmann, and M Véron, and P Berche
Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients.
February 2002, Lancet (London, England),
J Boukadida, and M De Montalembert, and G Lenoir, and P Scheinmann, and M Véron, and P Berche
Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients.
February 2002, Lancet (London, England),
J Boukadida, and M De Montalembert, and G Lenoir, and P Scheinmann, and M Véron, and P Berche
Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.
December 1994, The Journal of infectious diseases,
J Boukadida, and M De Montalembert, and G Lenoir, and P Scheinmann, and M Véron, and P Berche
Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.
November 2001, International journal of medical microbiology : IJMM,
J Boukadida, and M De Montalembert, and G Lenoir, and P Scheinmann, and M Véron, and P Berche
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
September 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
J Boukadida, and M De Montalembert, and G Lenoir, and P Scheinmann, and M Véron, and P Berche
Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis.
January 1993, Lancet (London, England),
J Boukadida, and M De Montalembert, and G Lenoir, and P Scheinmann, and M Véron, and P Berche
Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis.
December 2010, International journal of medical microbiology : IJMM,
Copied contents to your clipboard!